These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma. Wagner SJ; Friedman LI; Dodd RY Transfus Med Rev; 1991 Jan; 5(1):18-32. PubMed ID: 1802274 [No Abstract] [Full Text] [Related]
8. Pathogen-inactivated blood products for pediatric patients: blood safety, patient safety, or both? Jacquot C; Delaney M Transfusion; 2018 Sep; 58(9):2095-2101. PubMed ID: 30204950 [No Abstract] [Full Text] [Related]
9. In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using amotosalen. Cazenave JP; Aleil B; Wiesel ML; Laforêt M; Isola H Vox Sang; 2004 Apr; 86(3):201-2. PubMed ID: 15078258 [No Abstract] [Full Text] [Related]
18. [Transfusions of blood and blood products and virus infections]. Wróblewska M; Piotrowska E; ĺuczak M Postepy Hig Med Dosw; 2002; 56(2):221-40. PubMed ID: 12107964 [TBL] [Abstract][Full Text] [Related]
19. [Developments in blood transfusion]. Krusius T; Porkka K Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306 [No Abstract] [Full Text] [Related]
20. Evolution of microbial safety. Barbara JA Hematol J; 2004; 5 Suppl 3():S69-73. PubMed ID: 15190282 [No Abstract] [Full Text] [Related] [Next] [New Search]